Cell death research provides insights into cancer

February 4, 2014 by Kelly Stone
Cell death research provides insights into cancer

As today marks World Cancer Day, latest research from South Australia's Centre for Cancer Biology (CCB) may provide new insight into the understanding and treatment of cancer.

Published in high profile international scientific journal Nature Communications, the research from CCB co-director Professor Sharad Kumar and his team, including lead author research fellow Dr Donna Denton, looks at how a gene called UTX plays an important role in controlling .

This is significant because the spread of cancer from one organ to other parts of the body relies on cancer cells' ability to evade the cell death process.

The CCB is an alliance between the University of South Australia and SA Pathology and boasts the largest concentration of fundamental cancer research in the state.

This latest CCB research, funded by the National Health and Medical Research Council, specifically looked at how UTX plays a role in controlling cell death by regulating the expression of a number of other genes.

For more than 20 years Prof Kumar has been investigating the processes by which cells undergo death and the molecular machinery that determines whether a cell lives or dies.

Prof Kumar says cell death is essential to maintain the correct number of cells in the body and to get rid of cells that have been damaged and become potentially harmful. His laboratory uses animal models including the vinegar fly Drosophila to study how various genes control the process of cell death and how they determine which cells are specifically deleted during development.

"Cell death and survival are controlled by many genes, and defects in these genes are often linked to diseases. For example, the inability of to evade cell death is a well-known hallmark of cancer," Prof Kumar says.

"The vinegar fly has proved to be an excellent model to study cell death during development given its genetics are well understood; it is experimentally highly amenable and more than 60 per cent of human disease genes are conserved in the fly," Dr Denton says.

In the current study they identified that UTX, an 'epigenetic modifier', is necessary to maintain high levels of expression of a number of genes that are required for deleting a specific tissue at a precise time during the development of the fly.

"Interestingly, a similar human gene is often mutated in many cancer types," Dr Denton says.

"The work also indicates that UTX cooperates with a steroid hormone receptor to carry out its gene regulation function.

"Steroid hormones are important in many human cancers, including breast and prostate .

"Therefore our work may provide new insight into the understanding and ."

Explore further: Gene plays major role in suppressing cancer

Related Stories

Gene plays major role in suppressing cancer

November 18, 2013
Adelaide researchers have found that a specific gene plays an important role in suppressing lymphoma, a type of blood cell cancer.

New prostate cancer drugs may not be targeting root cause of disease, scientists warn

January 27, 2014
(Medical Xpress)—New drugs being developed for the treatment of prostate cancer may not be targeting the root cause of the disease, according to research published today (Friday, 24 January 2014) in Cell Death & Differentiation.

New paper offers insights into how cancer cells avoid cell death

June 19, 2013
(Medical Xpress)—A new study by a team of researchers from the University of Notre Dame provides an important new insight into how cancer cells are able to avoid the cell death process. The findings may reveal a novel chemotherapeutic ...

Researchers discover a tumor suppressor gene in a very aggressive lung cancer

January 9, 2014
The Genes and Cancer Group at the Cancer Epigenetics and Biology Program of the IDIBELL has found that the MAX gene, which encodes a partner of the MYC oncogene, is genetically inactivated in small cell lung cancer. Reconstitution ...

Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs

January 10, 2014
(Medical Xpress)—When a tumor is treated with an anti-cancer drug, some cells die and, unfortunately, some cells tend to live. A University of Colorado Cancer Center study published in the journal Nature Cell Biology details ...

Small molecule shows promise as anti-cancer therapy

January 13, 2014
Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.